title: [Prevention and treatment of erectile dysfunction after radical prostatectomy].
abstract: Radical prostatectomy is the curative surgical management of organ confined prostate cancer. Erectile dysfunction may follow surgery as the most common complication decreasing the quality of life of the patient. Thanks to spreading PSA screening probability increases to detect prostate cancer in its early stage and so the expected number of surgery is increasing, too. Higher number of operation as well as surgery more frequently performed in younger age calls the attention to the importance of erectile dysfunction and its management. Nowadays the physiology of erectile dysfunction due to radical prostatectomy has been revealed, and as a consequence, the nerve sparing surgery for its prevention is already known. The paper presents the different kind of possible invasive and non-invasive treatments of erectile dysfunction, and surveys their history and effectiveness. The erectile function of patients who underwent radical prostatectomy between 1998 and 2007 at the Department of Urology and Uro-oncological Centre was assessed by IIEF- and MMM questionnaire and letters with questions of habit of medicine taking. The results show that 59% of patients who desire sexual activity are capable of it spontaneously or with medical management.
authors.affiliation: Semmelweis Egyetem, Altalános Orvostudományi Kar, Urológiai Klinika, Budapest Ulloi út 78/B, 1082. rieszp@freemail.hu
authors.forename: Péter
authors.initials: P
authors.lastname: Riesz
authors.forename: András
authors.initials: A
authors.lastname: Rusz
authors.forename: Miklós
authors.initials: M
authors.lastname: Szucs
authors.forename: Attila
authors.initials: A
authors.lastname: Majoros
authors.forename: Péter
authors.initials: P
authors.lastname: Nyírády
authors.forename: Attila
authors.initials: A
authors.lastname: Keszthelyi
authors.forename: Miklós
authors.initials: M
authors.lastname: Szucs
authors.forename: Stelios
authors.initials: S
authors.lastname: Mavrogenis
authors.forename: Gábor
authors.initials: G
authors.lastname: Filkor
authors.forename: József
authors.initials: J
authors.lastname: Pánovics
authors.forename: Imre
authors.initials: I
authors.lastname: Romics
mesh_terms: D007172:Erectile Dysfunction / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy*; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000601:surgery*; D011788:Quality of Life; D011795:Surveys and Questionnaires
chemical_list: D010726:Phosphodiesterase Inhibitors; D017430:Prostate-Specific Antigen